Back
ServiceNow Vs. Blueprint Medicines Industry Stock Comparison
Buy
61
NOW
ServiceNow
Last Price:
$995.95
Seasonality Move:
8.33%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.27
Seasonality Move:
10.35%
Buy
61
ServiceNow (NOW)
is a Buy
Is ServiceNow a Buy, Sell or Hold?
-
The current ServiceNow [NOW] share price is $980.40. The Score for NOW is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
NOW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.40. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NOW Stock Price Chart
What is ServiceNow's stock price today?
-
The ServiceNow share price today is $980.40The current trend is relatively stagnant and NOW is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NOW Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.42 | Buy |
Relative Strength Index (14 RSI): | 45.55 | Sell |
Chaikin Money Flow: | 1016427 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (994.63 - 1026.35) | Sell |
Bollinger Bands (100): | (835.39 - 1034.43) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.37 | Buy |
Relative Strength Index (14 RSI): | 75.84 | Buy |
Chaikin Money Flow: | 2405267 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.82 - 130.54) | Buy |
Bollinger Bands (100): | (84.96 - 114.18) | Buy |
NOW Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 993.04 | Sell |
20-day SMA: | 1007.19 | Sell |
50-day SMA: | 960.04 | Buy |
200-day SMA: | 963.71 | Buy |
8-day EMA: | 991.42 | Sell |
20-day EMA: | 997.62 | Sell |
50-day EMA: | 973.44 | Buy |
200-day EMA: | 929.6 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.17 | Buy |
20-day SMA: | 121.09 | Buy |
50-day SMA: | 104.25 | Buy |
200-day SMA: | 96.1 | Buy |
8-day EMA: | 127.55 | Buy |
20-day EMA: | 121.54 | Buy |
50-day EMA: | 110.11 | Buy |
200-day EMA: | 98.48 | Buy |
ServiceNow Earnings Growth & NOW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.14 per share, an increase this year of $2.67 per share, and an increase next year of $3.28 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
ServiceNow Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |